OSELTAMIVIR APL oseltamivir (as phosphate) 30 mg hard capsule blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

oseltamivir phosphate, Quantity: 39.411 mg

Saadav alates:

Alembic Pharmaceuticals Australia Pty Ltd

Ravimvorm:

Capsule, hard

Koostis:

Excipient Ingredients: purified talc; pregelatinised maize starch; sodium stearylfumarate; povidone; croscarmellose sodium; indigo carmine; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; Shellac; strong ammonia solution; titanium dioxide; purified water; iron oxide yellow; iron oxide red; Gelatin

Manustamisviis:

Oral

Ühikuid pakis:

10

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Oseltamivir Phosphate is indicated for the treatment of infections due to influenza A and B viruses in adults and children including full-term neonates. Treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,Oseltamivir Phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. Vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Toote kokkuvõte:

Visual Identification: Opaque Light yellow cap/opaque Light yellow body hard gelatin capsules size 4 having imprinting A 292 on cap with blue ink.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2022-11-17